T15_Thompson_UPDATED_ ICM MGH 2013 Presented.pdf

More documents

Recommendations

Info

Bilateral Opacities c/w edema?YESFerguson et al <strong>ICM</strong> 2012 eSupplement
Distribution of patients acrosscategories of ARDS and Mortality22%ARDSN= 3670Mortality27%Mild50%28%32%Moderate45%SevereRubenfeld et al JAMA 2012
Page 1 and 2: Critical Care Update: 2013B. Taylor
Page 3 and 4: Outline• ARDS: a new definition a
Page 5: Berlin CXR Definitions/Refinements
Page 9 and 10: Guerin et al. 2013466 patients with
Page 11 and 12: ECMO?Increasing Intensity of Interv
Page 13 and 14: • Awakening Trial if Fi02 ≤ 0.5
Page 15 and 16: F I 0 2 = 0.4 - 0.5on ≤ 8 PEEPOpt
Page 20 and 21: Conservative estimates for small IC
Page 22 and 23: Sepsis Pathogenesis: key terms• P
Page 24 and 25: Immune Suppression with Sepsis• S
Page 26 and 27: No Benefit or Harm in 36 RCTs forSe
Page 28 and 29: Outline• ARDS: a new definition a
Page 30 and 31: Importance of Early AntibioticsKuma
Page 32: Lactate Clearance vs Scv02 GuidedEa
Page 35 and 36: NEJM 2004
Page 37 and 38: Isotonic Albumin• 250 ml of 5% al
Page 39 and 40: The use of dopamine increasedmortal
Page 41: Outline• ARDS: a new definition a
Page 44 and 45: Lower Mortality in Recent ReportsPR
Page 46 and 47: Surviving Sepsis: Inotropic Therapy
Page 48 and 49: Bilateral Opacities c/w edema?YESFe
Page 50: Surviving Sepsis: ScreeningScreenin

T15_Thompson_UPDATED_ ICM MGH 2013 Presented.pdf

Create successful ePaper yourself

Delete template?

Save as template?